Adam Smith

Adam Smith

University of Kansas

Assistant Professor

More

Haven't backed any projects yet! 

No lab notes posted yet!

I am excited to be apart of this collaborative work and appreciate the investments of those who choose to offer their support and "back this project". Dr. Moskovitz has identified a fundamental problem in the development of Alzheimer's disease prevention and treatment which is the ability to target this disease state early in its progression. Many therapeutics have been designed for molecular targets that emerge in later stages of the disease, which may contribute to their low success rate. This research will hopefully shift the focus of others in the research community to study the same early-stage prevention and treatment strategies.
Mar 06, 2019
Can we immunize against Alzheimer's disease?
View comment